The Effect of Erythrocyte-Containing Donor Blood Components in the Priming of the Cardiopulmonary Bypass Circuit on the Development of Systemic Inflammation During Correction of Congenital Heart Defects in Children

Various pathological factors accompanying any cardiac surgery can cause intraoperative systemic inflammatory responses (SIR). As the number of cardiac surgical interventions grows worldwide, the issue of SIR prevention appears highly relevant.Aim of the study. To determine the effect of not using dono...

Full description

Bibliographic Details
Main Authors: D. V. Borisenko, A. A. Ivkin, D. L. Shukevich, R. A. Kornelyuk
Format: Article
Language:English
Published: Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia 2022-06-01
Series:Общая реаниматология
Subjects:
Online Access:https://www.reanimatology.com/rmt/article/view/2237
_version_ 1797874121109929984
author D. V. Borisenko
A. A. Ivkin
D. L. Shukevich
R. A. Kornelyuk
author_facet D. V. Borisenko
A. A. Ivkin
D. L. Shukevich
R. A. Kornelyuk
author_sort D. V. Borisenko
collection DOAJ
description Various pathological factors accompanying any cardiac surgery can cause intraoperative systemic inflammatory responses (SIR). As the number of cardiac surgical interventions grows worldwide, the issue of SIR prevention appears highly relevant.Aim of the study. To determine the effect of not using donor blood components in the priming of the cardiopulmonary bypass circuit in children with septal congenital heart defects, operated under cardiopulmonary bypass, on the severity of SIR.Material and methods. A prospective, randomized study included 40 children with a median age of 14 [12–22.5] months and weight of 8.8 [7.25–11] kg. All patients underwent radical correction of septal defect under cardiopulmonary bypass. The patients were divided into two groups depending on the use of donor blood components for priming the CPB. The severity of SIR was assessed using four specific serum biomarkers such as interleukin 1b (IL-1b), interleukin 6 (IL-6), interleukin 10 (IL-10), and tumor necrosis factor alpha (TNF-α), measured before the operation, after the CPB and 16 hours after the surgery. In addition, the intra- and postoperative periods were evaluated.Results. The safety of the proposed strategy of skipping the donor blood was confirmed by lack of any organ dysfunction in all patients, as well as a significant difference in the balance of oxygen delivery and consumption. In addition, the levels of systemic inflammation markers after CPB were significantly higher in patients who had transfusion: IL-1b was 3.3 [3.2–3.48] pg/mL vs 2.86 [2.7–3.11] pg/mL (P=0.003) and TNF-α reached 1.81 [1.37–3.3] pg/mL vs 1.33 [1.26–1.76] pg/mL (P=0.034). Meanwhile, 16 hours post surgery, IL-6 and IL-10 levels were significantly higher in the group using donor blood components with IL-6 being 48.91 [33.89–57.6] pg/mL vs 31.56 [26.83–48.89] pg/mL (P=0.087) and IL-10 reaching 0.8 [0.76–1.43] pg/mL vs 0.69 [0.6–0.83] pg/mL (P=0.005).Conclusion. The study demonstrates and confirms the safety and efficacy of cardiopulmonary bypass without using donor blood components to reduce the severity of the systemic inflammatory response in children undergoing correction of septal congenital heart defects.
first_indexed 2024-04-10T01:26:54Z
format Article
id doaj.art-306ef525d50b4201a8b8f7f4afd6245a
institution Directory Open Access Journal
issn 1813-9779
2411-7110
language English
last_indexed 2024-04-10T01:26:54Z
publishDate 2022-06-01
publisher Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia
record_format Article
series Общая реаниматология
spelling doaj.art-306ef525d50b4201a8b8f7f4afd6245a2023-03-13T09:32:57ZengFederal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, RussiaОбщая реаниматология1813-97792411-71102022-06-01183303710.15360/1813-9779-2022-3-30-371850The Effect of Erythrocyte-Containing Donor Blood Components in the Priming of the Cardiopulmonary Bypass Circuit on the Development of Systemic Inflammation During Correction of Congenital Heart Defects in ChildrenD. V. Borisenko0A. A. Ivkin1D. L. Shukevich2R. A. Kornelyuk3Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеванийНаучно-исследовательский институт комплексных проблем сердечно-сосудистых заболеванийНаучно-исследовательский институт комплексных проблем сердечно-сосудистых заболеванийНаучно-исследовательский институт комплексных проблем сердечно-сосудистых заболеванийVarious pathological factors accompanying any cardiac surgery can cause intraoperative systemic inflammatory responses (SIR). As the number of cardiac surgical interventions grows worldwide, the issue of SIR prevention appears highly relevant.Aim of the study. To determine the effect of not using donor blood components in the priming of the cardiopulmonary bypass circuit in children with septal congenital heart defects, operated under cardiopulmonary bypass, on the severity of SIR.Material and methods. A prospective, randomized study included 40 children with a median age of 14 [12–22.5] months and weight of 8.8 [7.25–11] kg. All patients underwent radical correction of septal defect under cardiopulmonary bypass. The patients were divided into two groups depending on the use of donor blood components for priming the CPB. The severity of SIR was assessed using four specific serum biomarkers such as interleukin 1b (IL-1b), interleukin 6 (IL-6), interleukin 10 (IL-10), and tumor necrosis factor alpha (TNF-α), measured before the operation, after the CPB and 16 hours after the surgery. In addition, the intra- and postoperative periods were evaluated.Results. The safety of the proposed strategy of skipping the donor blood was confirmed by lack of any organ dysfunction in all patients, as well as a significant difference in the balance of oxygen delivery and consumption. In addition, the levels of systemic inflammation markers after CPB were significantly higher in patients who had transfusion: IL-1b was 3.3 [3.2–3.48] pg/mL vs 2.86 [2.7–3.11] pg/mL (P=0.003) and TNF-α reached 1.81 [1.37–3.3] pg/mL vs 1.33 [1.26–1.76] pg/mL (P=0.034). Meanwhile, 16 hours post surgery, IL-6 and IL-10 levels were significantly higher in the group using donor blood components with IL-6 being 48.91 [33.89–57.6] pg/mL vs 31.56 [26.83–48.89] pg/mL (P=0.087) and IL-10 reaching 0.8 [0.76–1.43] pg/mL vs 0.69 [0.6–0.83] pg/mL (P=0.005).Conclusion. The study demonstrates and confirms the safety and efficacy of cardiopulmonary bypass without using donor blood components to reduce the severity of the systemic inflammatory response in children undergoing correction of septal congenital heart defects.https://www.reanimatology.com/rmt/article/view/2237детикардиохирургияискусственное кровообращениесистемный воспалительный ответ
spellingShingle D. V. Borisenko
A. A. Ivkin
D. L. Shukevich
R. A. Kornelyuk
The Effect of Erythrocyte-Containing Donor Blood Components in the Priming of the Cardiopulmonary Bypass Circuit on the Development of Systemic Inflammation During Correction of Congenital Heart Defects in Children
Общая реаниматология
дети
кардиохирургия
искусственное кровообращение
системный воспалительный ответ
title The Effect of Erythrocyte-Containing Donor Blood Components in the Priming of the Cardiopulmonary Bypass Circuit on the Development of Systemic Inflammation During Correction of Congenital Heart Defects in Children
title_full The Effect of Erythrocyte-Containing Donor Blood Components in the Priming of the Cardiopulmonary Bypass Circuit on the Development of Systemic Inflammation During Correction of Congenital Heart Defects in Children
title_fullStr The Effect of Erythrocyte-Containing Donor Blood Components in the Priming of the Cardiopulmonary Bypass Circuit on the Development of Systemic Inflammation During Correction of Congenital Heart Defects in Children
title_full_unstemmed The Effect of Erythrocyte-Containing Donor Blood Components in the Priming of the Cardiopulmonary Bypass Circuit on the Development of Systemic Inflammation During Correction of Congenital Heart Defects in Children
title_short The Effect of Erythrocyte-Containing Donor Blood Components in the Priming of the Cardiopulmonary Bypass Circuit on the Development of Systemic Inflammation During Correction of Congenital Heart Defects in Children
title_sort effect of erythrocyte containing donor blood components in the priming of the cardiopulmonary bypass circuit on the development of systemic inflammation during correction of congenital heart defects in children
topic дети
кардиохирургия
искусственное кровообращение
системный воспалительный ответ
url https://www.reanimatology.com/rmt/article/view/2237
work_keys_str_mv AT dvborisenko theeffectoferythrocytecontainingdonorbloodcomponentsintheprimingofthecardiopulmonarybypasscircuitonthedevelopmentofsystemicinflammationduringcorrectionofcongenitalheartdefectsinchildren
AT aaivkin theeffectoferythrocytecontainingdonorbloodcomponentsintheprimingofthecardiopulmonarybypasscircuitonthedevelopmentofsystemicinflammationduringcorrectionofcongenitalheartdefectsinchildren
AT dlshukevich theeffectoferythrocytecontainingdonorbloodcomponentsintheprimingofthecardiopulmonarybypasscircuitonthedevelopmentofsystemicinflammationduringcorrectionofcongenitalheartdefectsinchildren
AT rakornelyuk theeffectoferythrocytecontainingdonorbloodcomponentsintheprimingofthecardiopulmonarybypasscircuitonthedevelopmentofsystemicinflammationduringcorrectionofcongenitalheartdefectsinchildren
AT dvborisenko effectoferythrocytecontainingdonorbloodcomponentsintheprimingofthecardiopulmonarybypasscircuitonthedevelopmentofsystemicinflammationduringcorrectionofcongenitalheartdefectsinchildren
AT aaivkin effectoferythrocytecontainingdonorbloodcomponentsintheprimingofthecardiopulmonarybypasscircuitonthedevelopmentofsystemicinflammationduringcorrectionofcongenitalheartdefectsinchildren
AT dlshukevich effectoferythrocytecontainingdonorbloodcomponentsintheprimingofthecardiopulmonarybypasscircuitonthedevelopmentofsystemicinflammationduringcorrectionofcongenitalheartdefectsinchildren
AT rakornelyuk effectoferythrocytecontainingdonorbloodcomponentsintheprimingofthecardiopulmonarybypasscircuitonthedevelopmentofsystemicinflammationduringcorrectionofcongenitalheartdefectsinchildren